Telephone consultation cannot replace bedside infectious disease consultation in the management of staphylococcus aureus bacteremia

Clinical Infectious Diseases

Volumn 56, Issue 4, 2013, Pages 527-535

  Forsblom, E ^a   Ruotsalainen, E ^a   Ollgren, J ^b   Jarvinen A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

deep infection foci; infectious disease specialist consultation; Staphylococcus aureus bacteraemia

Indexed keywords

BETA LACTAM ANTIBIOTIC; CORTICOSTEROID; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; CORTICOSTEROID THERAPY; ENDOCARDITIS; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OSTEOMYELITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEPSIS; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; TELECONSULTATION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; COMMUNICABLE DISEASES; DISEASE MANAGEMENT; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; REFERRAL AND CONSULTATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TELEPHONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84873044221     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis889     Document Type: Article

References (27)

1. Fowler VG Jr, Sanders LL, Sexton DJ, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998; 27:478-86.
2. Conterno LO, Wey SB, Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 1998; 19:32-7.
3. Fowler VG Jr, Sanders LL, Kong LK, et al. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with followup. Clin Infect Dis 1999; 28:106-14.
4. Choi SH, Cho SY, Park JH, Chung JW. Impact of infectious-disease specialist consultations on outcomes of Staphylococcus aureus bacteremia in a hospital with a low volume of patients with S. aureus bacteremia. J Infect 2011; 62:181-5.
5. Lahey T, Shah R, Gittzus J, Schwartzman J, Kirkland K. Infectious disease consultation lowers mortality from Staphylococcus aureus bacteremia. Medicine 2009; 88:263-7.
6. Honda H, Krauss MJ, Jones JC, Olsen MA, Warren DK. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med 2010; 123:631-7.
7. Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 46:1000-8.
8. Rieg S, Peyerl-Hoffmann G, de With K, et al. Mortality of S. aureus bacteremia and infectious diseases specialist consultation-a study of 521 patients in Germany. J Infect 2009; 59:232-9.
9. Nagao M, Iinuma Y, Saito T, et al. Close cooperation between infectious disease physicians and attending physicians results in better outcomes for patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2009; 16:1783-8.
10. Sellier E, Pavese P, Gennai S, Stahl JP, Labarère J, Francxois P. Factors and outcomes associated with physicians' adherence to recommendations of infectious disease consultations for inpatients. J Antimicrob Chemother 2010; 65:156-62.
11. Botelho-Nevers E, Thuny F, Casalta JP, et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med 2009; 169:1290-8.
12. Kuo D, Gifford DR, Stewin MD. Curbside consultations practices and attitudes among primary care physicians and medical specialists. JAMA 1998; 280:905-9.
13. Yinnon AM. Whither infectious diseases consultations? Analysis of 14,005 consultations from a 5-year period. Clin Infect Dis 2001; 15:1661-7.
14. Leblebicioglu H, Akbulut A, Ulusory M, et al. Informal consultations in infectious diseases and clinical microbiology practice. Clin Microbiol Infect 2003; 9:724-6.
15. Grace C, Alston WK, Ramundo M, Polish L, Kirkpatrick B, Huston C. The complexity, relative value, and financial worth of curbside consultations in an academic infectious disease unit. Clin Infect Dis 2010; 51:651-5.
16. Bal G, Sellier E, Gennai S, Caillis M, François P, Pavese P. Infectious disease specialist telephone consultations requested by general practitioners. Scand J Infect Dis 2011; 43:912-7.
17. Ruotsalainen E, Jarvinen A, Koivula I, et al. Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients. J Intern Med 2006; 259:179-90.
18. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30:633-8.
19. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-6.
20. McCabe WR, Jackson GG. Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 1962; 110:847-53.
21. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36:1418-23.
22. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AWCarmeli Y. Comparison of mortality associated with methicillinresistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36:53-9.
23. Pfaller MA, Jones RN, Doern GV, Sader HS, Kugler KC, Beach ML. Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRYParticipants Group. Diagn Microbiol Infect Dis 1999; 33: 283-97.
24. Finnish National Institute for Health and Welfare. Report 17/2011, page 28. http://www.thl.fi/thl-client/pdfs/1d73f597-8188-4ff5-b33c-101d7e1c3e90.
25. Siegman-Igra Y, Reich P, Orni-Wasserlauf R, Schwartz D, Giladi M. The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia. Scand J Infect Dis 2005; 37:572-8.
26. Mylotte JM, Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 2000; 31:1170-4.
27. Benfield T, Espersen F, Frimodt-Moller N, et al. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 2007; 13:257-63.